Feed Preview

Breast Cancer: Risk Factors

Breast Cancer: Risk Factors diagram by undefined

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Top 20 most recent papers
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical OncologyDecember 6, 2019
Philip D PoorvuAnn Hart Partridge
Scientific Reports

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing

Scientific ReportsDecember 6, 2019
Mev Dominguez-ValentinEivind Hovig
Cancer Discovery

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

Cancer DiscoveryDecember 5, 2019
Lillian M SmythDavid M. Hyman
Blood Advances

Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray

Blood AdvancesDecember 6, 2019
Diego VillaGraham W Slack
Scientific Reports

A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival

Scientific ReportsDecember 6, 2019
Athina GiannoudisCarlo Palmieri
Breast Cancer Research : BCR

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

Breast Cancer Research : BCRDecember 3, 2019
Samuel A JacobsKatherine L Pogue-Geile
Journal of the National Comprehensive Cancer Network : JNCCN

Testicular Cancer Survivorship

Journal of the National Comprehensive Cancer Network : JNCCNDecember 1, 2019
Chunkit FungLois B Travis
Breast Cancer Research : BCR

Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

Breast Cancer Research : BCRDecember 4, 2019
Sunil PancholiLesley-Ann Martin
Clinical Epigenetics

ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer

Clinical EpigeneticsDecember 4, 2019
Yan Fang WangTing-Xiu Xiang

Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia

MedicineDecember 1, 2019
Ying ChenBen-zhong Wang
Breast Cancer Research : BCR

Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells

Breast Cancer Research : BCRDecember 5, 2019
Monica M MontanoMatthew C Lawes
BMC Cancer

The impact of RNA extraction method on accurate RNA sequencing from formalin-fixed paraffin-embedded tissues

BMC CancerDecember 5, 2019
Michał MarczykWilliam Fraser Symmans

XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion

OncogenesisDecember 6, 2019
Jiheng XuChuan-shu Huang
Cell Death & Disease

miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4

Cell Death & DiseaseDecember 4, 2019
Fei-Ya DuWei Chen
Frontiers in Genetics

Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification

Frontiers in GeneticsNovember 19, 2019
Logan C. WalkerMiguel de la Hoya
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie

WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling

Biomedicine & Pharmacotherapy = Biomédecine & PharmacothérapieDecember 8, 2019
Jiao MaXiang-hui Han
Cell Death & Disease

Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin

Cell Death & DiseaseDecember 4, 2019
Kathleen SchmitCarine Michiels

How I treat NTRK gene fusion-positive cancers

ESMO OpenNovember 25, 2019
Ulrik Niels Lassen
Journal of Enzyme Inhibition and Medicinal Chemistry

Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds

Journal of Enzyme Inhibition and Medicinal ChemistryDecember 7, 2019
Ahmed Karam FaragEun Joo Roh
Cell Death & Disease

The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer

Cell Death & DiseaseDecember 4, 2019
Shou-Ping XuDa Pang

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

© 2019 Meta ULC. All rights reserved